ADB is committed to expand its health sector financing to 2-3% of its total portfolio, which translates to $1b of annual health sector approvals. Traditional loans are no longer attractive for countries, and many countries graduate from low income status, which means they can’t access grants and highly concessional loans anymore. At the same time ODA is decreasing. This requires innovative approaches to health financing and to provide countries with new financing options, that lead to results, are sustainable and affordable.